|
Market Closed -
Nasdaq
21:00:00 30/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 541.89 USD | +12.55% |
|
+10.72% | +11.21% |
| 09-30 | Healthcare Stocks Fall Amid Above-Target Inflation -- Healthcare Roundup | DJ |
| 09-30 | Sector Update: Healthcare Stocks Fall Late Afternoon | MT |
| Market Cap | 23.24B 20.46B 19.39B 17.5B 32.99B 2,228B 33.41B 232B 89.26B 1,139B 87.25B 85.35B 3,651B | P/E 2026 * |
20.8x | P/E 2027 * | 19x |
|---|---|---|---|---|---|
| Enterprise Value | 20.3B 17.88B 16.94B 15.29B 28.82B 1,946B 29.19B 203B 77.98B 995B 76.22B 74.56B 3,190B | EV / Sales 2026 * |
6.46x | EV / Sales 2027 * | 5.65x |
| Free-Float |
53.72% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| UTHR | Delayed | |
CBOE
| UTHR | Real-time | |
|
Tradegate
| UTH | Real-time | |
|
Boerse Muenchen
| UTH | Real-time | |
|
Deutsche Boerse AG
| UTH | Delayed | |
|
Börse Stuttgart
| UTH | Delayed | |
|
Berne S.E.
| UTH | End-of-day quote |
Last Transcript: United Therapeutics Corporation
| 1 day | +12.55% | ||
| 1 week | +10.72% | ||
| 1 month | +6.17% | ||
| 3 months | +0.01% | ||
| 6 months | -8.62% | ||
| Current year | +11.21% |
| 1 week | 470.4 |  | 557.37 |
| 1 month | 468.97 | | 557.37 |
| Current year | 455.63 | | 609.35 |
| 1 year | 409.07 | | 609.35 |
| 3 years | 208.62 | | 609.35 |
| 5 years | 158.38 | | 609.35 |
| 10 years | 74.31 | | 609.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 25/06/1996 | |
| President | 54 | 25/06/2016 | |
James Edgemond
DFI | Director of Finance/CFO | 58 | 12/03/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Raymond Kurzweil
BRD | Director/Board Member | 78 | 31/12/2001 |
| Chairman | 71 | 25/06/1996 | |
Louis Sullivan
BRD | Director/Board Member | 92 | 31/12/2001 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 28/09/26 | Exercice | Chief Executive Officer | 28,500 | 0.0671% | ||
| 25/09/26 | Exercice | Chief Executive Officer | 28,500 | 0.0671% | ||
| 24/09/26 | Exercice | Chief Executive Officer | 28,500 | 0.0671% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +12.55% | +10.72% | +29.26% | +139.91% | 20.65B | |
| -2.33% | +0.53% | +51.65% | +115.42% | 1,056B | |
| -1.06% | -1.65% | +42.78% | +69.98% | 645B | |
| -0.65% | -1.32% | +12.98% | +75.49% | 465B | |
| -2.66% | -1.87% | +73.13% | +41.15% | 368B | |
| -0.06% | -4.12% | +36.31% | +39.39% | 335B | |
| -0.79% | +3.01% | +21.11% | +27.79% | 275B | |
| -1.19% | -3.09% | +10.75% | +10.61% | 255B | |
| -0.50% | +3.80% | +49.37% | +56.84% | 229B | |
| -1.47% | -1.53% | +34.28% | +98.89% | 188B | |
| Average | +0.50% | -0.55% | +36.16% | +67.55% | 383.64B | |
| Weighted average by Cap. | -0.95% | -0.29% | +40.18% | +71.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.14B 2.77B 2.62B 2.37B 4.46B 301B 4.52B 31.35B 12.07B 154B 11.79B 11.54B 494B | 3.43B 3.02B 2.86B 2.59B 4.87B 329B 4.94B 34.26B 13.19B 168B 12.89B 12.61B 539B |
| Net income | 1.2B 1.06B 1B 903M 1.7B 115B 1.72B 11.97B 4.61B 58.77B 4.5B 4.4B 188B | 1.31B 1.16B 1.1B 990M 1.87B 126B 1.89B 13.12B 5.05B 64.41B 4.93B 4.83B 207B |
| Net Debt | -2.94B -2.59B -2.45B -2.21B -4.17B -282B -4.22B -29.31B -11.28B -144B -11.03B -10.78B -461B | -3.83B -3.38B -3.2B -2.89B -5.44B -368B -5.51B -38.27B -14.73B -188B -14.4B -14.08B -603B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/09/26 | US$541.89 | +12.55% | 3,336,554 |
| 29/09/26 | US$481.47 | -0.84% | 439,866 |
| 28/09/26 | US$485.54 | +2.12% | 628,267 |
| 25/09/26 | US$475.45 | +0.69% | 472,446 |
| 24/09/26 | US$472.21 | -3.52% | 585,524 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UTHR Stock
Select your edition
All financial news and data tailored to specific country editions
